- Home
- KYMR vs APTV Comparison
KYMR vs APTV Comparison
Compare KYMR & APTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KYMR | APTV |
|---|---|---|
| Founded | 2015 | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.1B | 9.5B |
| IPO Year | 2020 | 2011 |
Fundamental Metrics
Financial Performance| Metric | KYMR | APTV |
|---|---|---|
| Price | $106.49 | $43.14 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 24 | 20 |
| Target Price | ★ $139.35 | $65.06 |
| AVG Volume (30 Days) | 791.6K | ★ 3.3M |
| Earning Date | 11-03-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.06 |
| Revenue | $39,211,000.00 | ★ $20,398,000,000.00 |
| Revenue This Year | $167.23 | N/A |
| Revenue Next Year | N/A | $4.24 |
| P/E Ratio | ★ N/A | $21.49 |
| Revenue Growth | N/A | ★ 3.47 |
| 52 Week Low | $55.26 | $42.56 |
| 52 Week High | $130.05 | $88.93 |
Technical Indicators
Market Signals| Indicator | KYMR | APTV |
|---|---|---|
| Relative Strength Index (RSI) | 40.87 | 41.95 |
| Support Level | $100.63 | $42.77 |
| Resistance Level | $121.24 | $45.16 |
| Average True Range (ATR) | 5.07 | 1.06 |
| MACD | -0.31 | 0.18 |
| Stochastic Oscillator | 36.08 | 25.44 |
Price Performance
Historical ComparisonAbout KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.
About APTV Aptiv PLC
Aptiv PLC is an industrial technology company focused on enabling a more automated, electrified and digitalized future. The company's technologies reach from sensor to cloud, including the hardware and software necessary to support automotive and other industries on a global basis. Its Advanced Safety and User Experience segment provides advanced software and services, intelligent sensors and high-performance compute platforms; its Engineered Components Group segment provides connection systems, high-performance interconnects, and cable management and protection solutions; and its Electrical Distribution Systems segment provides low voltage and high voltage power, signal and data distribution.